IPD ANALYTICS Trademark
IPD ANALYTICS is a USPTO trademark filed by IPD Analytics, LLC. Status: Registered.
Trademark Facts
| Mark | IPD ANALYTICS |
|---|---|
| Serial Number | 88595214 |
| Registration Number | 6549932 |
| Status | Registered |
| Filing Date | 2019-08-27 |
| Registration Date | 2021-11-09 |
| Mark Type | Word |
| Nice Classes | 035 (Advertising & Business) |
| Owner | IPD Analytics, LLC |
| Attorney of Record | Julie A. Greenberg |
| Prosecution Events | 39 |
| Latest Event | APRE on 2022-06-07 |
Goods & Services
Strategic business consulting in the fields of market analysis, sales, and cost in the pharmacologic market segment featuring customizable economic models and underlying qualitative assumptions and particularly specializing in the use of analytic models for the understanding and predicting of trends and actions in the pharmacologic market segment; Business monitoring and consulting services in the pharmacologic market segment, namely, tracking web sites and applications of others to provide strategy, insight, market analysis, sales, and cost, particularly specializing in the use of analytic and statistic models for the understanding and predicting of trends and actions in the pharmacologic market segment, including customizable economic models and underlying qualitative assumptions; Business management consulting in the pharmacologic market segment with relation to strategy, market analysis, regulatory and policy analysis, reimbursability, and substitutability, particularly specializing in the use of analytic and statistic models for the understanding and predicting of trends and actions in the pharmacologic market segment, including customizable economic models and underlying qualitative assumptions; Analyzing and compiling business data covering products in the pharmacologic market segment featuring customizable economic models and underlying qualitative assumptions; Business data analysis in the pharmacologic market segment featuring customizable economic models and underlying qualitative assumptions; business consultation services, namely, providing drug life-cycle insights for others; business consultation services, namely, clinical, formulary, procurement, and inventory-control insights for others; economic forecasting services, namely, brand and generic market impact forecasts; medical drug coding services for others in the nature of drug and dosage administered for purposes of billing and reimbursement from insurance; business services, namely, providing business information online in the field of budget impact models in the pharmacologic market for others; "ANALYTICS"